Specialty· July 11, 2026 · 16 min read
Hemophilia Access 2026: Prophylaxis and Gene Therapy Post-Roctavian
By Ran Chen#Gene Therapy#Hematology#Payer Coverage
Topic
Hematology
Hematology therapies, oncology-adjacent access, evidence standards, buy-and-bill dynamics, and payer criteria.
Evidence· July 10, 2026 · 17 min read
Anticoagulant Adverse Events in FAERS: 244,000 Reports and Bleeding/HIT Profiles
Pipeline· June 2, 2026 · 10 min read
Orca-T allogeneic cell therapy PDUFA preview: access implications for AML, ALL, and MDS
By Ran Chen#PDUFA Date#FDA Approval#Hematology